Novartis Consumer Health Inc. (NCH) has recalled several over-the-counter products in the U.S., suspended operations at its Lincoln, NE facility, and taken a $120 million charge due to quality issues. NCH began a voluntary recall in the U.S. of certain configurations of Excedrin and NoDoz products, as well as Bufferin and Gas-X Prevention. In a press statement, the company said the recall is “a precautionary measure, because the products may contain stray tablets, capsules, or caplets fro...